Patents by Inventor Amy Grace DuPage

Amy Grace DuPage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD166 ANTIBODIES AND USES THEREOF
    Publication number: 20220242949
    Abstract: The present invention provides, among other things, an antibody or antigen-binding polypeptide that binds or is capable of binding CD166, compositions including the same, and uses thereof. In certain embodiments, an anti-CD166 antibody or antigen-binding polypeptide of the present invention binds or is capable of binding all or a portion of an intracellular domain (“ICD”) of CD166. The present invention also includes, among other things, a nucleic acid molecule encoding an antibody or antigen-binding polypeptide that binds or is capable of binding CD166. In various embodiments, an anti-CD166 antibody or antigen-binding polypeptide is useful in a method of detecting or treating a condition or disease.
    Type: Application
    Filed: November 9, 2021
    Publication date: August 4, 2022
    Inventors: Luc Roland Desnoyers, Amy Grace DuPage
  • Anti-CD166 antibodies and uses thereof
    Patent number: 11220544
    Abstract: The present invention provides, among other things, an antibody or antigen-binding polypeptide that binds or is capable of binding CD 166, compositions including the same, and uses thereof. In certain embodiments, an anti-CD 166 antibody or antigen-binding polypeptide of the present invention binds or is capable of binding all or a portion of an intracellular domain (“ICD”) of CD 166. The present invention also includes, among other things, a nucleic acid molecule encoding an antibody or antigen-binding polypeptide that binds or is capable of binding CD 166. In various embodiments, an anti-CD 166 antibody or antigen-binding polypeptide is useful in a method of detecting or treating a condition or disease.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: January 11, 2022
    Assignee: CytomX Therapeutics, Inc.
    Inventors: Luc Roland Desnoyers, Amy Grace DuPage
  • ANTI-CD166 ANTIBODIES AND USES THEREOF
    Publication number: 20200223919
    Abstract: The present invention provides, among other things, an antibody or antigen-binding polypeptide that binds or is capable of binding CD 166, compositions including the same, and uses thereof. In certain embodiments, an anti-CD 166 antibody or antigen-binding polypeptide of the present invention binds or is capable of binding all or a portion of an intracellular domain (“ICD”) of CD 166. The present invention also includes, among other things, a nucleic acid molecule encoding an antibody or antigen-binding polypeptide that binds or is capable of binding CD 166. In various embodiments, an anti-CD 166 antibody or antigen-binding polypeptide is useful in a method of detecting or treating a condition or disease.
    Type: Application
    Filed: July 13, 2018
    Publication date: July 16, 2020
    Inventors: Luc Roland Desnoyers, Amy Grace DuPage